TrialX Roundup: Supporting Global Patient Recruitment and Access to Clinical Trials, Space Health Innovation, Study Apps and More…
We wrapped up at the Patients as Partners in Clinical Research conference in Boston couple weeks back. The biggest takeaway: patients aren’t just participants — they’re essential partners in shaping better clinical trials and future treatments.
However, one theme echoed across sessions: making trials more accessible, inclusive, and easier to navigate isn’t optional anymore, it’s expected. While the industry has talked about patient centricity for years, the shift now is undeniable. Patients are demanding better access, simpler participation, greater transparency, and a true voice in their care. Notably, many patient advocates highlighted that trial endpoints, while clinically meaningful, don’t always reflect the outcomes that matter most to patients, such as symptom relief or quality of life.
Emerging technologies like AI will help address some of these challenges, but we can’t lose sight of what matters most. Clinical research is, first and foremost, human. The stories shared throughout the conference were a powerful reminder: disease doesn’t discriminate — and neither should we.
Our Senior Director of Client Services, Wes Martz, joined Krista Goedel from Sanofi on a panel to share innovative approaches to improving global patient recruitment and access to clinical trials. And our Co-founder & CEO, Sharib Khan, brought good energy (and balance) to the event with a fun, interactive yoga session, adding a refreshing dimension to the clinical research experience. Looking forward to continuing the conversation in London at Patients as Partners, Europe.
Beth Dickson, VP, Business Development
What’s New at TrialX! 🚀
🤝 RECENT CONFERENCE
We participated in the 2026 NASA HRP International Workshop on Space (IWS), bringing together leaders in space medicine and human performance to explore health in extreme environments. In collaboration with the Translational Research Institute for Space Health, TrialX presented its Space EHR system—designed to enable health data capture and research in remote and off-Earth settings. Learn More.
❇️ PRODUCT HIGHLIGHTS
We are proud to support Montefiore Medical Center and the University of Cincinnati in building the FORETELL-Epilepsy app, an NIH-funded initiative to advance seizure forecasting and improve patient care. The app enables adults living with epilepsy to contribute real-world data through daily diaries of seizures, mood, and stress, while integrating with wearable devices to track heart rate and sleep. The app is live and available on both app stores, with enrollment currently in progress. We are glad and honored that the investigators and study team felt supported throughout the process, sharing: “I wanted to take a moment to express our sincere appreciation for the time and effort TrialX has dedicated to supporting us with the apps and troubleshooting whenever issues arise.”
Recently, we introduced new enhancements to streamline our volunteer search and outreach. The improved interface enables more intuitive filtering with multi-select conditions and flexible location targeting, while saved searches allow teams to quickly reuse selection criteria. Users can now create volunteer lists for targeted outreach and track campaign performance with detailed engagement metrics, helping study teams identify, reach, and engage participants more efficiently. Learn More.
We supported a Top-5 pharma in successfully reaching their enrollment goal for a celiac disease clinical trial. By enabling engagement in 22 languages across 18 countries, and soon expanding to 40, we are proud to help sponsors and study teams run more inclusive trials and connect with the right participants in the right language, from local to global studies. Learn how we’re breaking down barriers to boost trial participation.
With NASA’s Artemis II—the first crewed mission to the Moon in over 50 years—marking a major step toward deep space exploration, the need for health monitoring in extreme, low-connectivity environments is more critical than ever. TrialX Space Health Systems is an offline-capable, AI-powered platform designed to collect and analyze diverse health datasets—from wearables to genomics—even without connectivity—enabling remote health research wherever the mission goes. In collaboration with the Translational Research Institute for Space Health (TRISH), we’ll be sharing more at the International Workshop on Space (IWS) and at the Aerospace Medical Association (AsMA) Annual Meeting in the coming months. Learn more.
📺 MEDIA & PRESS
Our Co-founder & CEO, Sharib Khan, was recently interviewed by Clinical Research News and featured in their online article – Space Health Research Could Rack Up Many Earthly Dividends. The article sheds light on how our space health research innovations, in collaboration with Translational Research Institute for Space Health (TRISH), are helping collect vital human-health data from commercial spaceflights, not just for astronauts, but with far-reaching implications for clinical research on Earth. Read the full story.
🛰️ RECENT WEBINAR
As commercial spaceflight expands, Earth-dependent imaging continues to face real constraints, including microgravity-driven physiological changes, communication delays and limited bandwidth. In a recent TrialX webinar, we explored how imaging systems can operate autonomously in zero-connectivity, high-risk environments and what these advances mean for remote and decentralized care on Earth. The discussion is relevant for teams working across space health, diagnostics, telemedicine, and clinical research.
RECENT CURETALKS 
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
Imaging Lung Inflammation in Smokers: This study uses advanced PET/CT imaging to compare lung inflammation across cigarette smokers, e-cigarette users, cannabis users, and non-smokers. Researchers aim to understand how different smoking behaviors impact inflammation in the lungs and brain.
Stronger Hearts, Healthier Lives: This study explores how physical activity patterns relate to cardiokidney metabolic (CKM) risk factors. Participants complete short surveys and wear an activity tracker, helping researchers design more effective exercise programs for at-risk individuals.
Investigational Treatment for CIDP: This global study evaluates a new investigational therapy for chronic inflammatory demyelinating polyneuropathy (CIDP), a rare neurological condition. Researchers are assessing whether the treatment can help reduce symptoms and improve daily functioning.
BLAAC PD Parkinson’s Research Study: Part of a global genetics initiative, this study collects health data and blood samples from Black and African American participants with and without Parkinson’s disease. The goal is to better understand genetic factors and support more inclusive research for future treatments.
🌎 AROUND THE WEB
🌕 NASA launched Artemis 2: What happens today could make or break the moon mission.
🩺 Smarter scans: FDA clears an ultrasound system for rapid pregnancy assessment.
🧠 Breakthrough: AI-powered stroke platform improves outcomes in a major clinical trial.
🚀 Brain in orbit: Spaceflight may shift the brain’s position, new research reveals.
💊 GLP-1 ripple: Drugs like Ozempic show expanding health benefits beyond weight loss.
‼️ NOTEWORTHY
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to simplify global patient recruitment management and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
All the best,
Team TrialX
